As of 2024-12-15, the Relative Valuation of InDex Pharmaceuticals Holding AB (INDEX.ST) is (228.63) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 45.30 SEK, the upside of InDex Pharmaceuticals Holding AB based on Relative Valuation is -604.7%.
The range of the Relative Valuation is (192.92) - (226.29) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 30.7x | 23.0x |
| Forward P/E multiples | 18.5x - 21.7x | 20.8x |
| Fair Price | (192.92) - (226.29) | (228.63) |
| Upside | -525.9% - -599.5% | -604.7% |
| Date | P/E |
| 2024-11-22 | -4.34 |
| 2024-11-21 | -4.28 |
| 2024-11-20 | -4.32 |
| 2024-11-19 | -4.59 |
| 2024-11-18 | -4.33 |
| 2024-11-15 | -4.27 |
| 2024-11-14 | -4.29 |
| 2024-11-13 | -4.30 |
| 2024-11-12 | -4.25 |
| 2024-11-11 | -4.27 |
| 2024-11-08 | -4.30 |
| 2024-11-07 | -4.25 |
| 2024-11-06 | -4.26 |
| 2024-11-05 | -4.32 |
| 2024-11-04 | -4.32 |
| 2024-11-01 | -4.31 |
| 2024-10-31 | -4.32 |
| 2024-10-30 | -4.28 |
| 2024-10-29 | -4.30 |
| 2024-10-28 | -4.31 |
| 2024-10-25 | -4.28 |
| 2024-10-24 | -4.32 |
| 2024-10-23 | -4.34 |
| 2024-10-22 | -4.36 |
| 2024-10-21 | -4.29 |
| 2024-10-18 | -4.22 |
| 2024-10-17 | -4.14 |
| 2024-10-16 | -4.12 |
| 2024-10-15 | -4.08 |
| 2024-10-14 | -3.97 |
| 2024-10-11 | -4.04 |
| 2024-10-10 | -4.03 |
| 2024-10-09 | -4.05 |
| 2024-10-08 | -4.06 |
| 2024-10-07 | -4.03 |
| 2024-10-04 | -4.00 |
| 2024-10-03 | -4.04 |
| 2024-10-02 | -4.07 |
| 2024-10-01 | -4.06 |
| 2024-09-30 | -4.04 |
| 2024-09-27 | -4.03 |
| 2024-09-26 | -4.08 |
| 2024-09-25 | -4.08 |
| 2024-09-24 | -4.12 |
| 2024-09-23 | -4.08 |
| 2024-09-20 | -4.10 |
| 2024-09-19 | -4.09 |
| 2024-09-18 | -4.18 |
| 2024-09-17 | -4.07 |
| 2024-09-16 | -4.08 |